摘要
目的:本研究旨在调查膳食益生元摄入量与阿尔茨海默病 (AD) 风险之间的关系。 方法:这项纵向研究包括 1,837 名老年人(≥65 岁)参与者,他们参加了一项基于多种族社区的队列研究,他们在基线时没有痴呆,并从食物频率问卷中提供了饮食信息。果聚糖(最著名的益生元之一)的每日总摄入量是根据食用频率和每份 8 种食物的果聚糖含量计算得出的。使用 Cox 比例风险模型检查每日果聚糖摄入量与 AD 风险的关联,并根据队列招募波、年龄、性别、种族/民族、教育、每日热量摄入和 APOE 基因型进行调整。通过在 Cox 模型中包含交互项以及分层分析,测试了种族/民族、APOE 基因型和性别的影响修正。 结果:在 1,837 名参与者(1,263 名女性 [69%];平均 [SD] 年龄 = 76 [6.3] 岁)中,平均随访 7.5 年(13736 人-年)期间发生了 391 例 AD 病例。每多摄入一克果聚糖,AD 风险降低 24%((95% CI)=0.60-0.97;P =0.03)。对吸烟、饮酒和合并症指数的额外调整并没有显着改变结果。尽管分层分析表明,果聚糖摄入与西班牙裔的 AD 风险降低显着相关,但与非西班牙裔黑人或白人无关。 结论:较高的膳食果聚糖摄入量与老年人临床阿尔茨海默病风险降低有关。
关键词: 膳食益生元消耗、阿尔茨海默病、痴呆症、APOE 基因型、中枢神经系统 (CNS)、帕金森病、多发性硬化症。
Current Alzheimer Research
Title:Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population
Volume: 18 Issue: 12
关键词: 膳食益生元消耗、阿尔茨海默病、痴呆症、APOE 基因型、中枢神经系统 (CNS)、帕金森病、多发性硬化症。
摘要:
Objective: This study aimed to investigate the association between dietary prebiotic intake and risk for Alzheimer’s disease (AD).
Methods: This longitudinal study includes 1,837 elderly (≥65 years) participants of a multi-ethnic community-based cohort study who were dementia-free at baseline and had provided dietary information from food frequency questionnaires. Total daily intake of fructan, one of the best-known prebiotics, was calculated based on consumption frequency and fructan content per serving of 8 food items. The associations of daily fructan intake with AD risk were examined using a Cox proportional hazards model, adjusted for cohort recruitment wave, age, gender, race/ethnicity, education, daily caloric intake, and APOE genotype. Effect modification by race/ethnicity, APOE genotype, and gender was tested by including an interaction term into the Cox models, as well as by stratified analyses.
Results: Among 1,837 participants (1,263 women [69%]; mean [SD] age = 76 [6.3] years), there were 391 incident AD cases during a mean follow-up of 7.5 years (13736 person-years). Each additional gram of fructan intake was associated with 24% lower risk for AD ((95% CI)=0.60-0.97; P =0.03). Additional adjusting for smoking, alcohol consumption, and comorbidity index did not change results materially. The associations were not modified by race/ethnicity, gender, and APOE genotype, although stratified analyses showed that fructan intake was significantly associated with reduced AD risk in Hispanics but not in non-Hispanic Blacks or Whites.
Conclusion: Higher dietary fructan intake is associated with a reduced risk of clinical Alzheimer’s disease among older adults.
Export Options
About this article
Cite this article as:
Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population, Current Alzheimer Research 2021; 18 (12) . https://dx.doi.org/10.2174/1567205019666211222115142
DOI https://dx.doi.org/10.2174/1567205019666211222115142 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats
CNS & Neurological Disorders - Drug Targets Myocardial Contrast Echocardiography: Role in Clinical Cardiology
Current Vascular Pharmacology Myocardial Insulin Resistance and Cardiac Complications of Diabetes
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Plasticity and Maintenance of Hematopoietic Stem Cells During Development
Recent Patents on Biotechnology The Metabolic Approach in Patients with Heart Failure: Effects on Left Ventricle Remodeling
Current Pharmaceutical Design Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Adiponectin as a Target in Obesity-related Inflammatory State
Endocrine, Metabolic & Immune Disorders - Drug Targets Comparison of Granulomatosis with Polyangiitis Clinical Features in Patients Depending on Involvement or Absence of Kidney Involvement
Current Rheumatology Reviews Use of Recombinant Factor VII in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery Glucose Metabolism and Insulin Resistance in Sepsis
Current Pharmaceutical Design The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition
Current Topics in Medicinal Chemistry The Potential Role of Statins in Pneumonia
Current Respiratory Medicine Reviews Application of Dual-Source CT Coronary Angiography in Type 2 Diabetic Patients with Symptomatic Coronary Heart Disease
Current Vascular Pharmacology Editorial [Hot Topic: Therapeutic Angiogenesis and Regeneration in Cardiovascular Diseases (Executive Editor: Masafumi Takahashi)]
Current Pharmaceutical Design Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences Nanofiber Scaffolds for Treatment of Spinal Cord Injury
Current Medicinal Chemistry The Role of Vascular Cell Senescence in Atherosclerosis: Antisenescence as a Novel Therapeutic Strategy for Vascular Aging
Current Vascular Pharmacology Safety of Vascular Endothelial and Hepatocyte Growth Factor Gene Therapy in Patients with Critical Limb Ischemia
Current Neurovascular Research